|
1
|
Petrick JL and McGlynn KA: The changing
epidemiology of primary liver cancer. Curr Epidemiol Rep.
6:104–111. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kim E and Viatour P: Hepatocellular
carcinoma: Old friends and new tricks. Exp Mol Med. 52:1898–1907.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kulik L and El-Serag HB: Epidemiology and
management of hepatocellular carcinoma. Gastroenterology.
156:477–491.e1. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nakatani T, Roy G, Fujimoto N, Asahara T
and Ito A: Sex hormone dependency of diethylnitrosamine-induced
liver tumors in mice and chemoprevention by leuprorelin. Jpn J
Cancer Res. 92:249–256. 2001.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Naugler WE, Sakurai T, Kim S, Maeda S, Kim
K, Elsharkawy AM and Karin M: Gender disparity in liver cancer due
to sex differences in MyD88-dependent IL-6 production. Science.
317:121–124. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Manieri E, Herrera-Melle L, Mora A,
Tomás-Loba A, Leiva-Vega L, Fernández DI, Rodríguez E, Morán L,
Hernández-Cosido L, Torres JL, et al: Adiponectin accounts for
gender differences in hepatocellular carcinoma incidence. J Exp
Med. 216:1108–1119. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lip GYH, Nieuwlaat R, Pisters R, Lane DA
and Crijns HJGM: Refining clinical risk stratification for
predicting stroke and thromboembolism in atrial fibrillation using
a novel risk factor-based approach: The euro heart survey on atrial
fibrillation. Chest. 137:263–272. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
O'Mahony C, Jichi F, Pavlou M, Monserrat
L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G,
McKenna WJ, et al: A novel clinical risk prediction model for
sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).
Eur Heart J. 35:2010–2020. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bogard N, Linder J, Rosenberg AB and
Seelig G: A deep neural network for predicting and engineering
alternative polyadenylation. Cell. 178:91–106.e23. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Deng YB, Nagae G, Midorikawa Y, Yagi K,
Tsutsumi S, Yamamoto S, Hasegawa K, Kokudo N, Aburatani H and
Kaneda A: Identification of genes preferentially methylated in
hepatitis C virus-related hepatocellular carcinoma. Cancer Sci.
101:1501–1510. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Villa E, Critelli R, Lei B, Marzocchi G,
Cammà C, Giannelli G, Pontisso P, Cabibbo G, Enea M, Colopi S, et
al: Neoangiogenesis-related genes are hallmarks of fast-growing
hepatocellular carcinomas and worst survival. Results from a
prospective study. Gut. 65:861–869. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang H, Huo X, Yang XR, He J, Cheng L,
Wang N, Deng X, Jin H, Wang N, Wang C, et al: STAT3-mediated
upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer
metastasis by regulating SOX4. Mol Cancer. 16(136)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang SM, Ooi LLPJ and Hui KM:
Identification and validation of a novel gene signature associated
with the recurrence of human hepatocellular carcinoma. Clin Cancer
Res. 13:6275–6283. 2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Leek JT, Johnson WE, Parker HS, Jaffe AE
and Storey JD: The sva package for removing batch effects and other
unwanted variation in high-throughput experiments. Bioinformatics.
28:882–883. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Abul-Hajj YJ, Iverson R and Kiang DT:
Metabolism of pregnenolone by human breast cancer. Evidence for 17
alpha-hydroxylase and 17,20-lyase. Steroids. 34:817–827.
1979.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Parker C and Sartor O: Abiraterone and
increased survival in metastatic prostate cancer. N Engl J Med.
365(767)2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Niu WX, Zhou CX, Cheng CD, Bao DJ, Dong
YF, Li DX, Yang Y, He H and Niu CS: Effects of lentivirus-mediated
CYP17A1 gene silencing on the biological activity of glioma.
Neurosci Lett. 692:210–215. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Robinson JL, Macarthur S, Ross-Innes CS,
Tilley WD, Neal DE, Mills IG and Carroll JS: Androgen receptor
driven transcription in molecular apocrine breast cancer is
mediated by FoxA1. Embo J. 30:3019–3027. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Camargo MC, Goto Y, Zabaleta J, Morgan DR,
Correa P and Rabkin CS: Sex hormones, hormonal interventions, and
gastric cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers
Prev. 21:20–38. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Marcinkiewicz K, Scotland KB, Boorjian SA,
Nilsson EM, Persson JL, Abrahamsson PA, Allegrucci C, Hughes IA,
Gudas LJ and Mongan NP: The androgen receptor and stem cell
pathways in prostate and bladder cancers (review). Int J Oncol.
40:5–12. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen PJ, Yeh SH, Liu WH, Lin CC, Huang HC,
Chen CL, Chen DS and Chen PJ: Androgen pathway stimulates
microRNA-216a transcription to suppress the tumor suppressor in
lung cancer-1 gene in early hepatocarcinogenesis. Hepatology.
56:632–643. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ceccarelli I, Rossi A, Maddalena M, Weber
E and Aloisi AM: Effects of morphine on testosterone levels in rat
C6 glioma cells: Modulation by anastrozole. J Cell Physiol.
221:1–4. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bao D, Cheng C, Lan X, Xing R, Chen Z,
Zhao H, Sun J, Wang Y, Niu C, Zhang B and Fang S: Regulation of
p53wt glioma cell proliferation by androgen receptor-mediated
inhibition of small VCP/p97-interacting protein expression.
Oncotarget. 8:23142–23154. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mann J: Natural products in cancer
chemotherapy: Past, present and future. Nat Rev Cancer. 2:143–148.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Li X, Li X, Huang N, Liu R and Sun R: A
comprehensive review and perspectives on pharmacology and
toxicology of saikosaponins. Phytomedicine. 50:73–87.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Du J, Song D, Cao T, Li Y, Liu J, Li B and
Li L: Saikosaponin-A induces apoptosis of cervical cancer through
mitochondria- and endoplasmic reticulum stress-dependent pathway in
vitro and in vivo: Involvement of PI3K/AKT signaling pathway. Cell
Cycle. 20:2221–2232. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang C, Zhang R, Chen X, Yuan M, Wu J, Sun
Q, Miao C and Jing Y: The potential effect and mechanism of
Saikosaponin A against gastric cancer. BMC Complement Med Ther.
23(295)2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang P, Lai X, Zhu MH, Long M, Liu XL,
Wang ZX, Zhang Y, Guo RJ, Dong J, Lu Q, et al: Saikosaponin A, a
triterpene saponin, suppresses angiogenesis and tumor growth by
blocking VEGFR2-mediated signaling pathway. Front Pharmacol.
12(713200)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fujita K and Nonomura N: Role of androgen
receptor in prostate cancer: A review. World J Mens Health.
37:288–295. 2019.PubMed/NCBI View Article : Google Scholar
|
